Home › Chronic Lymphocytic Leukemia › Colorado › Denver

Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Denver, CO

9 pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Denver (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Nagre-recruitPhase 3

Kaiser Permanente-Franklin, Denver

Edad 65 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07321652

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

AdventHealth Porter, Denver

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Nagre-recruitPhase 3

Saint Joseph Hospital ( Site 0026), Denver

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06136559

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Nagre-recruitPhase 3

CBCI, Colorado Blood Cancer Institute, Denver

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07648264

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Nagre-recruitPhase 2

Colorado Blood Institute, Denver

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221500

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

Colorado Blood Cancer Institute, Denver

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

Colorado Blood Cancer Institute, Denver

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Nagre-recruitPhase 1

Colorado Blood Cancer Institute, Denver

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05780034

Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Denver

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.